印度人群EKFC eGFR方程的重新校准
研究在1174名印度成人(615名健康者,559名CKD患者)中,用血浆碘海醇清除率测量mGFR,评估用印度特异性Q值和K值重新校准的EKFCcrea方程。结果显示,EKFCISK模型偏差最小(-1.2 ml/min/1.73 m2)、准确性最高(P30 69%)。
要点
- EKFCcrea在印度人群中平均偏差9.9 ml/min/1.73 m2,P30为58.1%。
- EKFCISK偏差-1.2 ml/min/1.73 m2,P30 69%,为最佳模型。
- 重新校准方程可改善印度CKD诊断与分期准确性。
核心结论
- 用印度特异性Q和K重新校准EKFCcrea可降低偏差并提高准确性,EKFCISK为最佳模型。
研究设计与样本
- 研究纳入1174名印度成人,其中健康者615名、CKD患者559名,平均年龄48岁,性别分布均衡。
- 以血浆碘海醇清除率评估mGFR,从健康个体推导印度特异性Q值,从40岁以下个体推导K值。
主要发现
- EKFCcrea方程平均偏差为9.9(95% CI: 8.7-11.1)ml/min/1.73 m2,P30为58.1%。
- EKFCISQ降低偏差至4.9(95% CI: 3.7-6.0)ml/min/1.73 m2,P30提高至64%。
- EKFCISK偏差为-1.2(95% CI: -0.1至-2.2)ml/min/1.73 m2,P30为69%。
- 与CKD-EPI 2021相比,EKFCISQ、EKFCISK和EKFCISQ+ISK分别使30%、48%和67%的CKD患者被重新分类到更低类别。
临床怎么用
- 在印度临床实践和公共卫生举措中,采用重新校准的EKFCISK方程可能带来更准确的CKD诊断和分期。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: The new European Kidney Function Consortium (EKFC) eGFR equation uses rescaled serum creatinine (SCr) to an age- and sex-specific normal median value, making it applicable across the entire age spectrum. We evaluated the performance of the recalibrated EKFCcrea equation using Indian-specific Q (for median SCr) and K (for normal glomerular filtration rate [GFR]) in a large Indian cohort and the ability to correctly classify chronic kidney disease (CKD). METHODS: Indian adults (healthy and patients with CKD) were recruited. Plasma iohexol clearance was used to assess measured GFR (mGFR). Indian-specific Q values were derived from healthy individuals, and K from those under the age of 40 years. We evaluated EKFCcrea, CKD- Epidemiology Collaboration (EPI)2021, and recalibrated the EKFCcrea equations, incorporating the Indian Q (ISQ), Indian constant (ISK), and both (ISQ + ISK). We evaluated bias and accuracy (P30) for all equations. RESULTS: A total of 1174 participants (615 healthy, 559 CKD), mean age 48 years, with equal sex distribution were recruited. The EKFCcrea equation showed a mean bias of 9.9 (95% CI: 8.7- 11.1) ml/min per 1.73 m2 with P30; 58.1%. EKFCISQ reduced bias to 4.9 (95% CI: 3.7 6.0) ml/min per 1.73 m2 and improved P30 to 64%. EKFCISK achieved a bias of -1.2 (95% CI: -0.1 to -2.2) ml/min per 1.73 m2 and P30 of 69%. 30%, 48%, and 67% of CKD patients were categorized into lower categories using the EKFCISQ, EKFCISK, and EKFCISQ+ISK equations, respectively, against the CKD-EPI 2021. CONCLUSION: Recalibrating EKFCcrea with Indian-specific Q and K reduced bias and improved accuracy, with EKFCISK emerging as the best model. Adopting this recalibrated equation in clinical practice and public health initiatives after validation in diverse cohorts could lead to more accurate CKD diagnosis and staging in India.
引用
- Yadav AK, Kaur J, Kaur R, et al. Recalibration of the European Kidney Function Consortium eGFR Equation for the Indian Population. Kidney Int Rep. 2026. PMID: 42254849. doi:10.1016/j.ekir.2026.106543
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。